Description

DILZEM 60MG

Indications

DILZEM 60MG, containing the active ingredient diltiazem, is primarily indicated for the management of hypertension and angina pectoris. It is often prescribed for patients who require effective blood pressure control and relief from chest pain associated with coronary artery disease. Additionally, DILZEM may be used in certain cases of supraventricular tachycardia to help regulate heart rate.

Mechanism of Action

Diltiazem, the active component of DILZEM, is classified as a calcium channel blocker. It exerts its therapeutic effects by inhibiting the influx of calcium ions through L-type calcium channels in cardiac and vascular smooth muscle. This inhibition leads to relaxation of vascular smooth muscle, resulting in vasodilation and a subsequent decrease in blood pressure. Furthermore, diltiazem reduces myocardial oxygen demand by decreasing heart rate and contractility, making it effective in alleviating angina symptoms.

Pharmacological Properties

DILZEM is characterized by its unique pharmacokinetic properties. After oral administration, diltiazem is well absorbed, with peak plasma concentrations typically reached within 1-3 hours. The drug undergoes extensive first-pass metabolism in the liver, leading to a bioavailability of approximately 40%. Diltiazem is highly protein-bound (about 80-90%) and has a half-life of 3-5 hours, although this may vary based on individual patient factors. The drug is primarily excreted in the urine as metabolites, with less than 5% of the dose appearing as unchanged drug.

Contraindications

DILZEM is contraindicated in patients with known hypersensitivity to diltiazem or any of its components. It should not be used in individuals with severe bradycardia, sick sinus syndrome, or advanced atrioventricular block without a functioning pacemaker. Additionally, DILZEM is contraindicated in patients with acute myocardial infarction and pulmonary congestion, as it may exacerbate these conditions. Caution is advised in patients with hepatic impairment, as the metabolism of diltiazem may be significantly altered.

Side Effects

Common side effects associated with DILZEM include dizziness, headache, fatigue, and peripheral edema. Gastrointestinal disturbances such as nausea, constipation, and abdominal discomfort may also occur. In some cases, patients may experience bradycardia or hypotension, particularly if the medication is initiated at a higher dose. Rare but serious side effects can include severe allergic reactions, liver enzyme elevations, and heart block. It is essential for patients to report any unusual symptoms to their healthcare provider promptly.

Dosage and Administration

The recommended starting dose of DILZEM for adults is typically 30mg to 60mg taken three times daily. Depending on the individual response and clinical condition, the dose may be titrated up to a maximum of 360mg per day. It is advisable to initiate treatment at the lowest effective dose to minimize the risk of side effects. DILZEM can be taken with or without food, but it is important to maintain a consistent administration schedule. Patients should be monitored regularly to assess blood pressure control and heart rate, adjusting the dose as necessary.

Interactions

DILZEM has the potential to interact with several medications, which may alter its effectiveness or increase the risk of adverse effects. Co-administration with other antihypertensive agents may lead to additive hypotensive effects. Caution should be exercised when using DILZEM with beta-blockers, as this combination can increase the risk of bradycardia and heart block. Additionally, diltiazem may inhibit the metabolism of certain drugs that are substrates of the cytochrome P450 system, particularly CYP3A4. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and herbal supplements.

Precautions

Before initiating treatment with DILZEM, a thorough medical history and assessment of the patient’s cardiovascular status should be conducted. Special caution is warranted in patients with a history of heart failure, as diltiazem may exacerbate this condition. Patients with renal or hepatic impairment should be closely monitored, and dose adjustments may be necessary. It is also important to evaluate patients for any potential drug interactions, particularly if they are on multiple medications. Patients should be advised to avoid alcohol consumption, as it may enhance the hypotensive effects of DILZEM.

Clinical Studies

Clinical studies have demonstrated the efficacy of DILZEM in reducing blood pressure and relieving angina symptoms. In a randomized controlled trial involving patients with essential hypertension, DILZEM significantly lowered systolic and diastolic blood pressure compared to placebo. Another study focused on patients with stable angina showed that diltiazem effectively improved exercise tolerance and reduced the frequency of angina episodes. Long-term studies have also indicated that DILZEM is well-tolerated and maintains its antihypertensive effects over extended periods. These findings support the use of DILZEM as a first-line treatment option for hypertension and angina.

Conclusion

DILZEM 60MG is a valuable therapeutic option for the management of hypertension and angina pectoris. Its mechanism of action as a calcium channel blocker allows for effective blood pressure reduction and alleviation of chest pain. While generally well-tolerated, it is essential for healthcare providers to monitor patients for potential side effects and interactions with other medications. With proper use and monitoring, DILZEM can significantly improve the quality of life for patients suffering from cardiovascular conditions.